Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yasuhiro Maejima has a total of 105 co-authors. Here are the top co-authors by number of shared publications:

  • Mitsuaki Isobe

    Department of Cardiovascular Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

    11 shared publications
  • Natsuko Tamura

    Department of Cardiovascular Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

    11 shared publications
  • Shun Nakagama

    Department of Cardiovascular Medicine Institute of Science Tokyo Tokyo Japan

    10 shared publications
  • Yuka Shiheido-Watanabe

    Department of Cardiovascular Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

    10 shared publications
  • Tetsuo Sasano

    Department of Cardiovascular Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

    9 shared publications
  • Kenzo Hirao

    Department of Cardiovascular Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

    8 shared publications

Latest Publications

  • Open Access

    Altered MicroRNA Signatures in Circulating Extracellular Vesicles Reflect Aortic Dilation in Takayasu Arteritis

    by Kohei Kawajiri, Shun Nakagama, Tetsuo Sasano, Yasuhiro Maejima

    Takayasu arteritis (TAK) is a large‐vessel vasculitis that can lead to aneurysmal dilation, yet reliable circulating biomarkers for vascular remodelling remain lacking. Extracellular vesicles (EVs) carry miRNAs implicated in vascular biology, but their relevance to TAK has not been fully explored. Circulating EVs were isolated from serum of 54 patients with TAK and healthy controls (HC), characterized, and profiled for miRNA content. Effects on endothelial cells (ECs) and monocytes were examined in vitro, and the diagnostic performance of EV‐associated miR‐223‐3p for aortic dilation was assessed by ROC analysis. Circulating EVs from patients with TAK exhibited a distinct miRNA profile compared with HC. HC‐EVs reduced the transcript abundance of ICAM‐1 and VCAM‐1 in ECs, an effect attenuated in TAK‐EVs and accompanied by enhanced monocyte adhesion. EV‐derived miR‐223‐3p was upregulated in TAK but selectively downregulated in patients with aortic dilation. EV‐associated miR‐223‐3p discriminated aortic dilation with an AUC of 0.748, exceeding that of CRP and ESR. Flow cytometric profiling revealed a reduction in platelet‐derived EVs in patients with aortic dilation. Reduced EV‐associated miR‐223‐3p is associated with aortic dilation in TAK and may serve as a candidate biomarker as an adjunct to imaging‐based assessment, warranting prospective validation in larger cohorts.

  • Open Access

    Altered MicroRNA Signatures in Circulating Extracellular Vesicles Reflect Aortic Dilation in Takayasu Arteritis

    by Kohei Kawajiri, Shun Nakagama, Tetsuo Sasano, Yasuhiro Maejima

    Background: Takayasu arteritis (TAK) is a large-vessel vasculitis characterized by progressive inflammation that can lead to stenosis or aneurysmal dilation. Reliable circulating biomarkers for vascular remodeling are lacking, and extracellular vesicles (EVs), which transport molecular cargo that reflects their cellular origin, have emerged as potential biomarkers and modulators of vascular inflammation. However, their role in TAK remains unclear. This study aimed to investigate the relationship between EV-derived microRNA (miRNA) signatures and clinically relevant vascular phenotypes, with a primary focus on aortic dilation. Methods: Circulating small EVs (sEVs) were isolated from the serum of patients with TAK and healthy controls, characterized by high-sensitivity flow cytometry, were profiled for miRNA content, and analyzed using bioinformatic pathway enrichment. In vitro assays were employed in assessing their impact on endothelial activation, while the diagnostic performance of miRNAs was compared to conventional biomarkers and clinical parameters. Results: sEVs from patients with TAK upregulated the endothelial expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, thereby enhancing monocyte adhesion in vitro, consistent with a pro-inflammatory phenotype. Differentially expressed miRNAs were enriched in PI3K–Akt signaling, with phosphatase and tensin homolog identified as a key predicted target. Among patients, miR-223-3p was selectively downregulated in those with aortic dilation, regardless of disease activity or treatment status. Receiver operating characteristic analysis showed that miR-223-3p identified aortic dilation with an area under the curve of 0.748, outperforming C-reactive protein and erythrocyte sedimentation rate. Flow cytometric analysis suggested that platelet-derived EVs represent a predominant source of circulating miR-223-3p, and their proportion tended to be reduced in patients with aortic dilation. Conclusions: Reduced platelet-derived EV–associated miR-223-3ps are associated with aortic dilation in TAK and demonstrate superior diagnostic accuracy over conventional inflammatory markers. EV miRNA profiling may provide a novel approach for evaluating vascular remodeling in TAK.

  • Open Access

    Ablating Myocardium Using Nanosecond Pulsed Electric Fields: Preclinical Assessment of Feasibility, Safety, and Durability

    by Moritz Nies, Keita Watanabe, Iwanari Kawamura, Bingyan J. Wang, Jeffrey Litt, Roman Turovskiy, David J. Danitz, Darrin R. Uecker, Keith E. Linder, Yasuhiro Maejima, et al.

    BACKGROUND: Unlike conventional microsecond pulsed electrical fields that primarily target the cell membranes, nanosecond pulses are thought to primarily electroporate intracellular organelles. We conducted a comprehensive preclinical assessment of catheter-based endocardial nanosecond pulsed field ablation in swine. METHODS: A novel endocardial nanosecond pulsed field ablation system was evaluated in a total of 25 swine. Using either a low-dose (5-second duration) or high-dose (15-second duration) strategy, thoracic veins and discrete atrial and ventricular sites were ablated. Predetermined survival periods were P =0.007). The esophagus revealed nontransmural adventitial surface lesions in 5 of 5 (100%) animals euthanized early (2 days) post-ablation. In the 10 animals euthanized later (14–28 days), all animals demonstrated significant esophageal healing—8 with complete resolution, and 2 with only trace fibrosis. CONCLUSIONS: A novel, endocardial nanosecond pulsed field ablation system provides acute and durable venous isolation and linear lesions. Transient phrenic injury and nontransmural esophageal lesions can occur with worst-case assessments suggesting limits to pulsed field ablation tissue selectivity and the need for dedicated assessments during clinical studies.


  • Open Access

    Prevalence of amyloid deposition and cardiac amyloidosis in shoulder disease compared to carpal tunnel syndrome

    by Eriku Yamada, Tomoyuki Umemoto, Towako Taguchi, Iichiroh Onishi, Akiko Yamamoto, Kazuya Tsukamoto, Takuya Ibara, Toru Sasaki, Hidetoshi Kaburagi, Yasuhiro Maejima, et al.


  • Open Access

    Porphyromonas gingivalis, a periodontal pathogen, impairs post-infarcted myocardium by inhibiting autophagosome–lysosome fusion

    by Yuka Shiheido-Watanabe, Yasuhiro Maejima, Shun Nakagama, Qintao Fan, Natsuko Tamura, Tetsuo Sasano

    While several previous studies have indicated the link between periodontal disease (PD) and myocardial infarction (MI), the underlying mechanisms remain unclear. Autophagy, a cellular quality control process that is activated in several diseases, including heart failure, can be suppressed by Porphyromonas gingivalis (P.g.). However, it is uncertain whether autophagy impairment by periodontal pathogens stimulates the development of cardiac dysfunction after MI. Thus, this study aimed to investigate the relationship between PD and the development of MI while focusing on the role of autophagy. Neonatal rat cardiomyocytes (NRCMs) and MI model mice were inoculated with wild-type P.g. or gingipain-deficient P.g. to assess the effect of autophagy inhibition by P.g. Wild-type P.g.-inoculated NRCMs had lower cell viability than those inoculated with gingipain-deficient P.g. This study also revealed that gingipains can cleave vesicle-associated membrane protein 8 (VAMP8), a protein involved in lysosomal sensitive factor attachment protein receptors (SNAREs), at the 47th lysine residue, thereby inhibiting autophagy. Wild-type P.g.-inoculated MI model mice were more susceptible to cardiac rupture, with lower survival rates and autophagy activity than gingipain-deficient P.g.-inoculated MI model mice. After inoculating genetically modified MI model mice (VAMP8-K47A) with wild-type P.g., they exhibited significantly increased autophagy activation compared with the MI model mice inoculated with wild-type P.g., which suppressed cardiac rupture and enhanced overall survival rates. These findings suggest that gingipains, which are virulence factors of P.g., impair the infarcted myocardium by cleaving VAMP8 and disrupting autophagy. This study confirms the strong association between PD and MI and provides new insights into the potential role of autophagy in this relationship.


  • Open Access

    Endoplasmic Reticulum Selective Autophagy Alleviates Anthracycline-Induced Cardiotoxicity

    by Shun Nakagama, Yasuhiro Maejima, Qintao Fan, Yuka Shiheido-Watanabe, Natsuko Tamura, Kensuke Ihara, Tetsuo Sasano


  • Open Access

    Porphyromonas gingivalis, a periodontal pathogen, Impairs Post-infarcted Myocardium by Inhibiting Autophagosome–Lysosome Fusion

    by Yuka Shiheido-Watanabe, Shun Nakagama, Qintao Fan, Natsuko Tamura, Tetsuo Sasano, Yasuhiro Maejima

    While several previous studies have indicated the link between periodontal disease (PD) and myocardial infarction (MI), the underlying mechanisms remain unclear. Autophagy, a cellular quality control process that is activated in several diseases, including heart failure, can be suppressed by Porphyromonas gingivalis (P.g.). However, it is uncertain whether autophagy impairment by periodontal pathogens stimulates the development of cardiac dysfunction after MI. Thus, this study aimed to investigate the relationship between PD and the development of MI while focusing on the role of autophagy. Neonatal rat cardiomyocytes (NRCMs) and MI model mice were inoculated with wild-type P.g. or gingipain-deficient P.g. to assess the effect of autophagy inhibition by P.g. Wild-type P.g.-inoculated NRCMs had lower cell viability than gingipain-deficient P.g.-inoculated NRCMs. The study also found that gingipain cleaves vesicle-associated membrane protein 8 (VAMP8), a protein involved in lysosomal sensitive factor attachment protein receptors (SNAREs), at the 47th lysine residue, inhibiting autophagy. Wild-type P.g.-inoculated MI model mice were more susceptible to cardiac rupture, with lower survival rates and autophagy activity than gingipain-deficient P.g.-inoculated MI model mice. Genetically modified MI model mice (VAMP8-K47A) were inoculated with wild-type P.g., and they exhibited significantly increased autophagy activation compared to wild-type P.g.-inoculated MI model mice, which suppressed cardiac rupture and enhanced overall survival rates. These findings suggest that gingipains, virulence factors of P.g., impair the infarcted myocardium by cleaving VAMP8 and disrupting autophagy. This study confirms the strong association between PD and MI and provides new insight into the potential role of autophagy in this relationship.

  • Open Access

    The Pathophysiological Significance of “Mitochondrial Ejection” from Cells

    by Qintao Fan, Yasuhiro Maejima, Lai Wei, Shun Nakagama, Yuka Shiheido-Watanabe, Tetsuo Sasano

    Mitochondria have beneficial effects on cells by producing ATP and contributing to various biosynthetic procedures. On the other hand, dysfunctional mitochondria have detrimental effects on cells by inducing cellular damage, inflammation, and causing apoptosis in response to various stimuli. Therefore, a series of mitochondrial quality control pathways are required for the physiological state of cells to be maintained. Recent research has provided solid evidence to support that mitochondria are ejected from cells for transcellular degradation or transferred to other cells as metabolic support or regulatory messengers. In this review, we summarize the current understanding of the regulation of mitochondrial transmigration across the plasma membranes and discuss the functional significance of this unexpected phenomenon, with an additional focus on the impact on the pathogenesis of cardiovascular diseases. We also provide some perspective concerning the unrevealed mechanisms underlying mitochondrial ejection as well as existing problems and challenges concerning the therapeutic application of mitochondrial ejection.


  • Open Access

    Endoplasmic reticulum selective autophagy alleviates anthracycline-induced cardiotoxicity

    by Shun Nakagama, Yasuhiro Maejima, Qintao Fan, Yuka Shiheido-Watanabe, Nastuko Tamura, Kensuke Ihara, Tetsuo Sasano

    Unfolded protein response (UPR) plays a critical role for preventing death of cardiomyocytes induced by excessive endoplasmic reticulum (ER) in response to cytotoxicity of anthracycline antineoplastic drugs through mitigating misfoled proteins accumulation in the hearts. Here, we demonstrate that ER-selective autophagy (ER-phagy) serves as a salvage system which enable cardiomyocytes to survive even if UPR fails to restore ER stress induced by doxorubicin (Dox), an anthracycline drug, by using in-house developed monitoring systems to evaluate the activity of ER-phagy in cardiomyocytes. Notably, ER-phagy contributes to relieving cardiac damage induced by Dox administration and is mediated by CCPG1, an ER-phagy receptor protein. Furthermore, ablation of CCPG1 abolished ER-phagy and worsened Dox-induced cardiac damage by inducing excessive ER stress-associated apoptosis. Our data highlight a compensatory role of CCPG1-driven ER-phagy in reducing Dox toxicity and pose a potential therapeutic target to intervene against Dox induced cardiomyopathy.

  • Open Access

    Neutrophil extracellular traps-mediated Beclin-1 suppression aggravates atherosclerosis by inhibiting macrophage autophagy

    by Masataka Sano, Yasuhiro Maejima, Shun Nakagama, Yuka Shiheido-Watanabe, Natsuko Tamura, Kenzo Hirao, Mitsuaki Isobe, Tetsuo Sasano

    A growing body of evidence suggests that neutrophil extracellular traps (NETs) critically contribute to the development of atherosclerosis. However, the detailed mechanism of how NETs promote atherogenesis remains unknown. In this study, we explored the role of NETs for promoting atherosclerosis by modulating the activity of autophagy in macrophages. NETs were effectively induced by a nicotine administration to the HL-60 cell-derived neutrophil-like cells. Treatment with NETs markedly suppressed both autophagosome formation and autophagosome–lysosome fusion in 7-ketocholesterol-treated macrophages, which are accompanied by the enhancement of inflammasome activity. NETs upregulate epidermal growth factor receptor (EGFR) activity, which enhances Beclin-1 phosphorylation of the tyrosine residues of Beclin-1 by EGFR, inhibits the PI3 kinase activity of the Beclin1–Vps34 complex, and suppresses autophagosome formation in macrophages. Furthermore, NET-induced activation of EGFR allows Rubicon to increase its expression, thereby suppressing autophagosome-lysosome fusion. In vivo experiments revealed that the suppression of NET formation by ablating peptidyl arginine deiminase-4 in neutrophil leukocytes resulted in the attenuation of atherosclerotic plaques in a nicotine-administered HFD-fed ApoE−/−mice. Taken together, these results suggest that NET-mediated EGFR–Beclin-1 signaling in the macrophages promotes atherogenesis by autophagy inhibition-mediated inflammasome activation.